4//SEC Filing
Bjork Elisabeth 4
Accession 0001140361-24-044548
CIK 0001281895other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:05 PM ET
Size
5.2 KB
Accession
0001140361-24-044548
Insider Transaction Report
Form 4
Bjork Elisabeth
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-09-26+607→ 607 totalExercise: $17.60Exp: 2034-09-26→ Common Stock (607 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 607 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on September 26, 2025.
Documents
Issuer
ROCKET PHARMACEUTICALS, INC.
CIK 0001281895
Entity typeother
Related Parties
1- filerCIK 0001810406
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 5:05 PM ET
- Size
- 5.2 KB